CFA
FOLD

CT Financial Advisors’s Amicus Therapeutics FOLD Stock Holding History

CT Financial Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$2.67K Buy
375
+270
+257% +$1.71K ﹤0.01% 543
2016
Q4 		$522 Hold
105
– – ﹤0.01% 608
2016
Q3 		$777 Hold
105
– – ﹤0.01% 594
2016
Q2 		$573 Hold
105
– – ﹤0.01% 610
2016
Q1 		$888 Hold
105
– – ﹤0.01% 584
2015
Q4 		$1.02K Buy
+105
New +$946 ﹤0.01% 582

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CT Financial Advisors's FOLD Position: Q1 2017 in Review

CT Financial Advisors increased its Amicus Therapeutics (FOLD) stake by 257% in Q1 2017, buying an estimated $1.71K and bringing the position to 375 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #543.

CT Financial Advisors first reported a position in FOLD in Q4 2015 and has held it in 6 quarters since. 134 funds tracked by Wall St. Rank hold FOLD as of Q1 2017.

  • CT Financial Advisors held 375 shares of Amicus Therapeutics worth $2.67K as of Q1 2017.
  • CT Financial Advisors bought 270 Amicus Therapeutics shares in Q1 2017, an estimated $1.71K.
  • Amicus Therapeutics made up ﹤0.01% of CT Financial Advisors's portfolio in Q1 2017, its #543 holding.
  • CT Financial Advisors first reported a position in Amicus Therapeutics in Q4 2015 and has held it in 6 quarters since.
  • 134 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.